Why this top broker says the Medibank (ASX:MPL) share price will hit new, all-time highs in 2022

Medibank shares could reach a new high in 2022.

| More on:
a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Limited (ASX: MPL) share price could hit a new, all-time high in 2022 according to a leading broker.

Medibank is the largest private health provider in Australia with its Medibank and ahm brands.

What broker has high expectations for the Medibank share price?

Credit Suisse currently rates Medibank as a buy with a price target of $3.70. That implies the Medibank shares could rise by close to 10% over the next year, if the broker is right.

If the Medibank share price did indeed reach $3.70 in 2022, then that would be a new all-time high for the business.

Credit Suisse notes that Medibank continues to grow its total number of policyholders, which is helping it increase its market share.

The broker referenced Medibank's latest update at its annual general meeting (AGM) when coming up with its recent thoughts for the business.

AGM update

Medibank is committed to returning any permanent net claims savings due to COVID back to customers and it expects to confirm the next segment of customer support before the end of the year.

Management said that its strong policyholder growth has continued with the addition of around 21,000 policyholders in the first four months of this financial year.

Due to that above growth, and the assumption that industry participation growth will be slower in FY22 relative to FY21, it's now aiming to grow by at least 3% in FY22, including growth in the Medibank brand.

On an underlying basis, Medibank is expecting average net claims per policy to be in line with the second half of FY21, or 2.4% among resident policyholders.

Medibank also highlighted that it's transforming into a health company, with preventative health and new models of care enabling the business to provide people with even more support to manage their health and wellbeing.

The digital offering is a key part of Medibank's plan to support day to day engagement with customers, allowing for a more personalised and connected health experience.

Medibank share price valuation

Based on the broker Credit Suisse's profit projections for FY22, the Medibank share price is valued at 21x FY22's estimated earnings with a grossed-up dividend yield of 5.4%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »